Determine the necessary mass, volume, or concentration for preparing a solution.
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
SKU | Size | Availability | Price | Qty |
---|---|---|---|---|
U166815-10mg | 10mg | Available within 4-8 weeks(?) Items will be manufactured post-order and can take 4-8 weeks. Thank you for your patience! | $75.90 | |
U166815-50mg | 50mg | Available within 4-8 weeks(?) Items will be manufactured post-order and can take 4-8 weeks. Thank you for your patience! | $162.90 | |
U166815-250mg | 250mg | Available within 4-8 weeks(?) Items will be manufactured post-order and can take 4-8 weeks. Thank you for your patience! | $733.90 | |
U166815-1g | 1g | Available within 4-8 weeks(?) Items will be manufactured post-order and can take 4-8 weeks. Thank you for your patience! | $2,640.90 |
Synonyms | Ulipristal acetate|126784-99-4|Ella|EllaOne|CDB-2914|CDB 2914|Ulipristal acetate [USAN]|Ella norpregnadiene|UNII-YF7V70N02B|VA2914|YF7V70N02B|(8S,11R,13S,14S,17R)-17-acetyl-11-(4-(dimethylamino)phenyl)-13-methyl-3-oxo-2,3,6,7,8,11,12,13,14,15,16,17-dodeca |
---|---|
Specifications & Purity | 98% (HPLC) |
Storage Temp | Store at -20°C |
Shipped In | Dry ice |
Action Type | AGONIST, ANTAGONIST, MODULATOR |
Mechanism of action | Progesterone receptor modulator |
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
IUPAC Name | [(8S,11R,13S,14S,17R)-17-acetyl-11-[4-(dimethylamino)phenyl]-13-methyl-3-oxo-1,2,6,7,8,11,12,14,15,16-decahydrocyclopenta[a]phenanthren-17-yl] acetate |
---|---|
INCHI | InChI=1S/C30H37NO4/c1-18(32)30(35-19(2)33)15-14-27-25-12-8-21-16-23(34)11-13-24(21)28(25)26(17-29(27,30)3)20-6-9-22(10-7-20)31(4)5/h6-7,9-10,16,25-27H,8,11-15,17H2,1-5H3/t25-,26+,27-,29-,30-/m0/s1 |
InChi Key | OOLLAFOLCSJHRE-ZHAKMVSLSA-N |
Canonical SMILES | CC(=O)C1(CCC2C1(CC(C3=C4CCC(=O)C=C4CCC23)C5=CC=C(C=C5)N(C)C)C)OC(=O)C |
Isomeric SMILES | CC(=O)[C@]1(CC[C@@H]2[C@@]1(C[C@@H](C3=C4CCC(=O)C=C4CC[C@@H]23)C5=CC=C(C=C5)N(C)C)C)OC(=O)C |
PubChem CID | 130904 |
Molecular Weight | 475.62 |
ChEMBL Ligand | CHEMBL260538 |
---|---|
PubChem CID | 130904 |
CAS Registry No. | 126784-99-4 |
ChEBI | CHEBI:71025 |
Wikipedia | Ulipristal acetate |
RCSB PDB Ligand | 2S0 |
PEP | ulipristal acetate |
DrugCentral Ligand | 4166 |
Enter Lot Number to search for COA:
To view the certificate results,please click on a Lot number.For Lot numbers from past orders,please use our order status section
Lot Number | Certificate Type | Date | Item |
---|---|---|---|
![]() | Certificate of Analysis | Aug 06, 2022 | U166815 |
Specific Rotation[α] | 179° (C=1,CHCl3) |
---|---|
Melt Point(°C) | 186 °C |
Pictogram(s) | GHS08,GHS07 |
---|---|
Signal | Danger |
Hazard Statements | H319,H335,H302,H312,H332,H360,H361,H362 |
Precautionary Statements | P261,P305+P351+P338,P280,P302+P352,P321,P405,P501,P264,P260,P271,P270,P304+P340,P403+P233,P362+P364,P330,P263,P203,P264+P265,P301+P317,P318,P317,P337+P317,P319 |
1. Attardi BJ, Burgenson J, Hild SA, Reel JR. (2004) In vitro antiprogestational/antiglucocorticoid activity and progestin and glucocorticoid receptor binding of the putative metabolites and synthetic derivatives of CDB-2914, CDB-4124, and mifepristone.. J Steroid Biochem Mol Biol, 88 (3): (277-88). [PMID:15120421] |